- Home
- BIYA vs NRSN Comparison
BIYA vs NRSN Comparison
Compare BIYA & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIYA
- NRSN
- Stock Information
- Founded
- BIYA 2017
- NRSN 2017
- Country
- BIYA China
- NRSN Israel
- Employees
- BIYA N/A
- NRSN N/A
- Industry
- BIYA
- NRSN Biotechnology: Pharmaceutical Preparations
- Sector
- BIYA
- NRSN Health Care
- Exchange
- BIYA NYSE
- NRSN Nasdaq
- Market Cap
- BIYA 61.6M
- NRSN 58.8M
- IPO Year
- BIYA 2025
- NRSN 2021
- Fundamental
- Price
- BIYA $0.72
- NRSN $1.91
- Analyst Decision
- BIYA
- NRSN Buy
- Analyst Count
- BIYA 0
- NRSN 2
- Target Price
- BIYA N/A
- NRSN $14.00
- AVG Volume (30 Days)
- BIYA 2.9M
- NRSN 442.8K
- Earning Date
- BIYA 05-13-2025
- NRSN 07-11-2025
- Dividend Yield
- BIYA N/A
- NRSN N/A
- EPS Growth
- BIYA N/A
- NRSN N/A
- EPS
- BIYA N/A
- NRSN N/A
- Revenue
- BIYA $12,809,211.00
- NRSN N/A
- Revenue This Year
- BIYA N/A
- NRSN N/A
- Revenue Next Year
- BIYA N/A
- NRSN N/A
- P/E Ratio
- BIYA N/A
- NRSN N/A
- Revenue Growth
- BIYA 10.66
- NRSN N/A
- 52 Week Low
- BIYA $0.59
- NRSN $0.51
- 52 Week High
- BIYA $8.00
- NRSN $2.60
- Technical
- Relative Strength Index (RSI)
- BIYA N/A
- NRSN 51.18
- Support Level
- BIYA N/A
- NRSN $2.04
- Resistance Level
- BIYA N/A
- NRSN $2.35
- Average True Range (ATR)
- BIYA 0.00
- NRSN 0.25
- MACD
- BIYA 0.00
- NRSN -0.04
- Stochastic Oscillator
- BIYA 0.00
- NRSN 28.74
About BIYA BAIYA INTERNATIONAL GROUP INC
Baiya International Group Inc is a company which operates through its subsidiary Gongwuyuan operates a cloud-based internet platform to provide one-stop crowdsourcing recruitment and SaaS-enabled HR solutions in the flexible employment marketplace. The Company's business is focused around on four primary services which are job matching services, entrusted recruitment services, project outsourcing services and abor dispatching services in the flexible employment market within China, mainly in the core manufacturing regions including the Pearl River Delta and Yangtze River Delta region.
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.